Search for: "Abbvie, Inc."
Results 121 - 140
of 143
Sorted by Relevance
|
Sort by Date
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
16 Aug 2021, 6:32 am
” Furthermore, drugmakers AbbVie, Teva, and Endo are also missing from the settlement even though they “have been accused of misleadingly marketing their pain medicines as safe. [read post]
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
7 Feb 2019, 12:08 pm
AbbVie, Inc., in the Northern District of Texas; United States ex rel. [read post]
11 Jan 2024, 12:03 am
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
5 Mar 2024, 10:55 am
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
1 Dec 2021, 1:29 pm
Pfizer, Inc. [read post]
4 Apr 2016, 11:21 am
| Actavis v Lilly | EU public consultation on neighbouring rights | Life as an IP Lawyer in San Francisco | Copyright in chess games | Trade surplus and IP | Fujifilm Kyowa Biologics v AbbVie Biotechnology. [read post]
28 Mar 2016, 2:59 am
It addresses declaratory reliefs, jurisdiction to grant them, and delves into the leading case on declaratory relief in patent cases - ie Arrow Generics Ltd v Merck & Co Inc [2007] EWHC 1900. [read post]
9 Apr 2021, 10:01 am
AbbVie Inc. v. [read post]
13 Jan 2015, 8:17 am
Manufactured by AbbVie Inc., a drugmaker that spun off Abbott Laboratories in 2013, Androgel has 60% of the testosterone replacement therapy market. [read post]
24 Jul 2019, 6:22 am
Legal background regarding Arrow-declarations The underlying jurisdiction was established in Arrow Generics v Merck & Co Inc [2007] FSR 39 and approved by the Court of Appeal in Fujifilm v AbbVie [2017] EWCA Civ. 1. [read post]
5 May 2015, 4:00 am
Janssen Inc.). [read post]
9 Jan 2022, 1:45 am
In Abbvie v Janssen, for example, a claim directed to a functionally defined anti-Il-12 antibody was found invalid for lack of written description despite disclosure in the specification of 300 example antibodies. [read post]
9 Aug 2018, 4:54 pm
In the nearly three years since the Delaware Court of Chancery first signaled its hostility to the proliferation of so-called disclosure-only merger lawsuits (culminating in the landmark In re Trulia, Inc. [read post]
19 Mar 2014, 9:00 am
It has been 15 years since the last brand v brand challenge of a biologic patent in Canada. [read post]
23 Apr 2024, 10:28 am
See, Amgen Inc. v. [read post]
11 Nov 2022, 9:40 am
Cir. 2021); Plexxikon Inc. v. [read post]
15 Jul 2019, 5:01 am
Abbvie Prods. [read post]
4 Jun 2018, 3:04 pm
But as Richmond Newspapers, Inc. v. [read post]
